SCHEMBL6562346

SCHEMBL6562346

CC(NC(N)=S)C(C)(C)C

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
TAS1R3 Q7RTX0 3/20 0.34
TAS1R1 Q7RTX1 3/20 0.34
TAS1R2 Q8TE23 3/20 0.34
ALDH1A1 P00352 5/20 0.34
HTT P42858 3/20 0.34
ALOX12 P18054 1/20 0.33
MEN1 O00255 3/20 0.32
KMT2A Q03164 3/20 0.32
POLB P06746 2/20 0.32
LMNA P02545 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HPGD P15428 3/20 0.32
HSD17B10 Q99714 2/20 0.32
PTGS2 P35354 1/20 0.32
KDM4E B2RXH2 1/20 0.32
DPP4 P27487 1/20 0.31
GAA P10253 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5801167 0.79 CYP3A4 (0.35) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL2582007 0.77 ALDH1A1 (0.30) ALDH1A1HPGDHSD17B10PTGS2
SCHEMBL2582012 0.77 ALDH1A1 (0.30) ALDH1A1HPGDHSD17B10PTGS2
Water SCHEMBL5144834 0.77 CYP3A4 (0.34) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL22508527 0.74 CYP3A4 (0.35) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL4850022 0.74 CYP3A4 (0.44) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL16206286 0.72 CYP3A4 (0.32) CYP3A4CYP2C9CYP2C19TAS1R3TAS1R1
SCHEMBL329850 0.71
SCHEMBL6033539 0.69
SCHEMBL1551404 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4177072-A HYDROPHILIC AND OLEOPHILIC AREAS FUJI PHOTO FILM CO., LTD. (JP) 1979-12-04 US claimed
US-11772085-B2 Far superior oxidation catalysts based on macrocyclic compounds CARNEGIE MELLON UNIVERSITY (US) 2023-10-03 US disclosed
EP-4015511-A1 OXIDATION CATALYSTS BASED ON MACROCYCLIC COMPOUNDS CARNEGIE MELLON UNIVERSITY (US) 2022-06-22 EP disclosed
EP-1085009-B1 INDAN DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2004-11-10 EP disclosed
EP-0934296-B1 CHROMAN DERIVATIVES NISSAN CHEMICAL IND LTD (JP) 2003-06-04 EP disclosed
US-6486178-B1 Indane derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2002-11-26 US disclosed
EP-1085009-A1 INDAN DERIVATIVES Nissan Chemical Industries, Ltd. (JP) 2001-03-21 EP disclosed
US-6066631-A Chroman derivatives NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-05-23 US disclosed
WO-2000012492-A1 BENZOXAZINE DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2000-03-09 WO disclosed
EP-0934296-A1 CHROMAN DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LIMITED (JP) 1999-08-11 EP disclosed
WO-1998004542-A1 CHROMAN DERIVATIVES NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 1998-02-05 WO disclosed
EP-0239896-B1 N,N'-DIHALO-2-IMIDAZOLIDINONES PPG INDUSTRIES, INC. (US) 1990-09-05 EP disclosed
EP-0381504-A2 Improvements in and relating to guanidine derivatives ELI LILLY AND COMPANY (US) 1990-08-08 EP disclosed
EP-0239896-A1 N,N'-Dihalo-2-imidazolidinones PPG INDUSTRIES, INC. (US) 1987-10-07 EP disclosed
US-4177072-A HYDROPHILIC AND OLEOPHILIC AREAS FUJI PHOTO FILM CO., LTD. (JP) 1979-12-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11772085-B2 Far superior oxidation catalysts based on macrocyclic compounds SOD1, ME3, ME2 CYP3A4 831/4885CYP2C9 2571/4885CYP2C19 2863/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.